meta_pixel
Tapesearch Logo
Log in
Wall Street Breakfast

Stocks poised for a decade of low returns

Wall Street Breakfast

Seeking Alpha

News, Business News, Investing, Business

4.11K Ratings

🗓️ 20 July 2023

⏱️ 6 minutes

🧾️ Download transcript

Summary

Transcript

Click on a timestamp to play from that location

0:00.0

Welcome to Seeking Alpha's Wall Street Lunch, our afternoon update on today's market action news and analysis.

0:09.0

Good afternoon, today's Thursday, July 20th, and I'm your host, Kim Kahn.

0:14.4

Earnings continue to roll in and will get to some big names later on, but first I want to share a

0:18.6

prediction that's generating a lot of chatter.

0:21.1

Historically, passive S&P 500 investors have been able to count on 10% annual returns

0:26.7

on average. But a lot depends on when you enter an exit, of course. For the next decade,

0:31.5

the return on U.S. stocks may not average much more than bonds

0:34.4

according to strategies for Bernstein who are looking at data going back

0:38.0

more than 100 years. For stocks Sarah McCarthy and Mark Diver say the Schiller PE, which uses a long-term inflation-adjusted view of earnings to reduce the effect of swings, is a good predictor out 10 years.

0:51.0

They say the current level of the Schiller PE in the US is elevated at 29.3 times

0:57.1

compared to history and implies returns of just 4% over the next 10 years. That's down from 12% in the previous decade.

1:05.0

For bonds, the current US 10-year yield is the best predictor, they say,

1:09.0

noting US bonds have delivered a meager 1.3% total return annualized since 2013.

1:15.0

That's almost an all-time low.

1:17.0

But this is expected to improve to 3.5% due to higher inflation and the rate tightening cycle.

1:23.0

I'll put a link in the show notes to the story where you can get charts for all these projections,

1:27.0

and there'll be one in the Wall Street lunch story on Seeking Alpha.

1:31.0

Now on the earnings front.

1:33.0

JNJ topped Wall Street forecasts thanks mainly to better than expected results in

1:37.0

pharmaceutical and medtech.

1:39.1

The company also raised the midpoints of its 2023 full-year guidance, excluding sales of its COVID-19 vaccine.

1:46.0

Abbott Lads beat estimates.

...

Please login to see the full transcript.

Disclaimer: The podcast and artwork embedded on this page are from Seeking Alpha, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of Seeking Alpha and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.

Copyright © Tapesearch 2026.